Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $2,000,000; ~4 awards anticipated; R21/R33 activity code.
Summary: Supports research evaluating the impact of HIV immunotherapies on central nervous system (CNS) outcomes in people with HIV, focusing on efficacy, safety, and mechanisms.
Key Information: This is a forecasted opportunity; dates and details may change when officially posted.